Literature DB >> 31832695

[Radiotherapy versus transoral robotic surgery for primary treatment of oropharyngeal squamous cell carcinoma: randomisation decides].

Alexander Fabian1, David Krug2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31832695     DOI： 10.1007/s00066-019-01567-x

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  9 in total

Review 1.  Surgery Versus Radiotherapy for Early Oropharyngeal Tumors: a Never-Ending Debate.

Authors:  Yan Monnier; Christian Simon
Journal:  Curr Treat Options Oncol       Date:  2015-09

2.  Minimally Invasive Radical Hysterectomy for Cervical Cancer: When Adoption of a Novel Treatment Precedes Prospective, Randomized Evidence.

Authors:  Alexander Melamed; J Alejandro Rauh-Hain; Pedro T Ramirez
Journal:  J Clin Oncol       Date:  2019-09-27       Impact factor: 44.544

3.  Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.

Authors:  Bhaswanth Dhanireddy; Nicolas P Burnett; Sreeja Sanampudi; Charles E Wooten; Jon Slezak; Brent Shelton; Lauren Shelton; Andrew Shearer; Susanne Arnold; Mahesh Kudrimoti; Thomas J Gal
Journal:  Am J Otolaryngol       Date:  2019-06-04       Impact factor: 1.808

Review 4.  Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma - A systematic review of the literature.

Authors:  D H Yeh; S Tam; K Fung; S D MacNeil; J Yoo; E Winquist; D A Palma; A C Nichols
Journal:  Eur J Surg Oncol       Date:  2015-09-26       Impact factor: 4.424

5.  Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.

Authors:  Vanita Noronha; Amit Joshi; Vijay Maruti Patil; Jaiprakash Agarwal; Sarbani Ghosh-Laskar; Ashwini Budrukkar; Vedang Murthy; Tejpal Gupta; Anil K D'Cruz; Shripad Banavali; Prathamesh S Pai; Pankaj Chaturvedi; Devendra Chaukar; Nikhil Pande; Arun Chandrasekharan; Vikas Talreja; Dilip Harindran Vallathol; Vijayalakshmi Mathrudev; Aparna Manjrekar; Kamesh Maske; Arati Sanjay Bhelekar; Kavita Nawale; Sadhana Kannan; Vikram Gota; Atanu Bhattacharjee; Shubhada Kane; Shashikant L Juvekar; Kumar Prabhash
Journal:  J Clin Oncol       Date:  2017-12-08       Impact factor: 44.544

Review 6.  Transoral Endoscopic Head and Neck Surgery and Its Role Within the Multidisciplinary Treatment Paradigm of Oropharynx Cancer: Robotics, Lasers, and Clinical Trials.

Authors:  F Christopher Holsinger; Robert L Ferris
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

7.  Hemorrhage after transoral robotic-assisted surgery.

Authors:  Scott A Asher; Hilliary N White; Alexandra E Kejner; Eben L Rosenthal; William R Carroll; J Scott Magnuson
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04-12       Impact factor: 3.497

8.  Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.

Authors:  Jennifer R Cracchiolo; Shrujal S Baxi; Luc G Morris; Ian Ganly; Snehal G Patel; Marc A Cohen; Benjamin R Roman
Journal:  Cancer       Date:  2016-03-11       Impact factor: 6.860

9.  Analysis of readmissions after transoral robotic surgery for oropharyngeal squamous cell carcinoma.

Authors:  Harman S Parhar; Elizabeth Gausden; Jayendrakumar Patel; Eitan Prisman; Donald W Anderson; J Scott Durham; Barret Rush
Journal:  Head Neck       Date:  2018-08-13       Impact factor: 3.147
  9 in total
  1 in total

1.  [ORATOR2 trial: randomized comparison of primary surgery vs. primary radiotherapy for HPV-associated oropharyngeal cancer in the context of de-escalated therapy].

Authors:  Alexander Fabian; Nils H Nicolay; David Krug
Journal:  Strahlenther Onkol       Date:  2022-08-01       Impact factor: 4.033
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.